Key Events This Week
15 Jun: Stock opens at Rs.239.30, declines 3.88%
16 Jun: Technical momentum shifts amid mixed signals
16 Jun: Valuation shifts signal renewed price attractiveness
19 Jun: Week closes at Rs.235.60, down 0.31% on day

Indoco Remedies Ltd Faces Technical Momentum Shift Amid Mixed Market Signals
2026-06-16 08:03:45Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex technical landscape for investors to navigate.
Read full news article
Indoco Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-06-16 08:01:03Indoco Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing sector headwinds and a challenging market environment. This repositioning, underscored by a significant decline in its price-to-earnings ratio and a relatively modest price-to-book value, offers investors a fresh perspective on the stock’s price attractiveness compared to its peers and historical benchmarks.
Read full news articleIndoco Remedies Surges 20.27%: Key Valuation and Technical Shifts Drive Rally
2026-06-13 13:02:55
Key Events This Week
8 June: Stock opens at Rs.199.80, down 3.48% amid broad market weakness
10 June: Valuation shifts signal renewed price attractiveness
11 June: Intraday high of Rs.223.35 with 7.33% surge
12 June: Strong price momentum with mixed technical signals, closes at Rs.248.95

Indoco Remedies Ltd is Rated Strong Sell
2026-06-13 10:10:51Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.
Read full news article
Indoco Remedies Ltd Sees Mixed Technical Signals Amid Strong Price Momentum
2026-06-12 08:02:36Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a strong intraday rally pushing the stock price to ₹244.05, up 18.79% from the previous close of ₹205.45, the technical landscape presents a blend of bullish and bearish signals that investors must carefully analyse.
Read full news article
Indoco Remedies Ltd Surges 7.33% to Day's High of Rs 223.35 — Outperforms Sector by 7.28 Percentage Points
2026-06-11 10:46:40The Sensex edged down by 0.05% on 11 Jun 2026, while Indoco Remedies Ltd surged 7.33%, touching an intraday high of Rs 223.35. This 7.28 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally amid a broadly subdued market environment.
Read full news article
Indoco Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-06-10 08:00:56Indoco Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing sector headwinds. This repositioning comes amid a backdrop of subdued returns relative to the broader market and a deteriorating profitability profile, raising important considerations for investors evaluating its price attractiveness against peers and historical benchmarks.
Read full news article
Indoco Remedies Ltd is Rated Strong Sell
2026-06-02 10:10:35Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleIndoco Remedies Limited - Press Release
01-Nov-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding a press release dated November 01, 2019, titled "Approval of Glycopyrrolate ANDAfiled from Indoco's Goa Plant II".
Indoco Remedies Limited - Updates
31-Oct-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding 'Publication of Unaudited Financial Results for the quarter and half year ended 30.09.2019 in newspapers'.
Indoco Remedies Limited - Press Release
18-Oct-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding a press release dated October 18, 2019, titled "Indoco s Clinical Research Organisation receives zero 483s from USFDA".
Corporate Actions
No Upcoming Board Meetings
Indoco Remedies Ltd has declared 10% dividend, ex-date: 04 Sep 25
Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12
Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12
No Rights history available






